Overall market sentiment has been down on InspireMD Inc (NSPR) stock lately. NSPR receives a Bearish rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.
InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.
Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .
What's Happening With NSPR Stock Today?
InspireMD Inc (NSPR) stock is higher by 14.29% while the S&P 500 is down -0.02% as of 3:26 PM on Friday, Feb 19. NSPR is up $0.15 from the previous closing price of $1.05 on volume of 22,526,535 shares. Over the past year the S&P 500 is higher by 15.56% while NSPR is up 3.45%. NSPR lost -$1.26 per share in the over the last 12 months.
To see InvestorsObserver's Sentiment Score for InspireMD Inc click here.
More About InspireMD Inc
InspireMD Inc is the United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Germany, Italy, Belarus, Brazil, and other countries.
Click Here to get the full Stock Score Report on InspireMD Inc (NSPR) Stock.
